Addiction Archives - Purablis-Medicinal Tinctures with CBD, THCA and THC

Addiction Marijuana Studies and

Addiction Cannabis Research

09/27/2018

Author(s): Yanhua Ren,1 John Whittard,1 Alejandro Higuera-Matas,2 Claudia V. Morris,1 and Yasmin L. Hurd1.

Using an animal model, this study examines the effects of CBD on the self-administration of heroin and concludes that it can be used effectively in patients with heroin addiction. View study

09/27/2018

Author(s): Gregory Stuart, Editor in Chief Copyright: © the authors, publisher and licensee Libertas Academica Limited. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.

Some preclinical studies say that cannabidiol (CBD) can have therapeutic properties on opiates, cocaine and psychostimulant addiction. They also suggest that CBD may be beneficial for the consumption of cannabis and tobacco in humans. However, more studies are needed to fully verify the potential of the CBD. View study

09/27/2018

Author(s): Amanda Reiman.

This study was conducted based on data collected in an anonymous survey to examine the use of alcohol and drugs, and the occurrence of substitution among medicinal cannabis patients. It was found that the reasons for the substitution were: fewer adverse side effects (65%), better management of symptoms (57%) and less potential for abstinence (34%) with cannabis. As a result of this study it was found that medicinal cannabis patients have been participating in the substitution using cannabis as an alternative to alcohol, prescriptions and illicit drugs. View study

09/27/2018

Author(s): Jun-Xu Li* , Wouter Koek, and Charles P. France.

THC does not significantly improve the positive reinforcing effects of heroin, further supporting the view that the combination of cannabinoids and opioid receptor agonists does not increase, and may reduce the abuse of individual drugs. View study

09/27/2018

Author(s): Rafael Maldonado, Olga Valverde and Fernando Berrendero.

Due to their properties, CB1 cannabinoid antagonists could contribute to the treatment of drug addiction, allowing the development of pharmacological compounds that can be used safely. View study

09/27/2018

Author(s): Marcus A. Bachhuber, MD; Brendan Saloner, PhD; Chinazo O. Cunningham, MD, MS; Colleen L. Barry, PhD, MPP.

Based on the results of this study, it was determined that the medical laws on cannabis are associated with significantly lower death rates from opioid overdoses at the state level. Deeper studies are required to determine how medical cannabis laws can interact with policies aimed at preventing overdoses of opioid analgesics. View study